Literature DB >> 24398101

Effects of simvastatin on retinal structure and function of a high-fat atherogenic mouse model of thickened Bruch's membrane.

Veluchamy A Barathi1, Sia W Yeo, Robyn H Guymer, Tien Y Wong, Chi D Luu.   

Abstract

PURPOSE: To determine the effect of a statin (simvastatin) on the ultrastructure and function of the RPE, Bruch's membrane (BM), and photoreceptor interface in a high-fat atherogenic mouse model of thickened BM.
METHODS: Wild-type C57BL/6 mice (6-weeks old) were divided into three study groups according to their diet and treatment given; Group 1, normal chow diet-fed mice; Group 2, high fat diet (HFD) fed mice; and Group 3, HFD-fed mice treated with simvastatin daily for 30 weeks. All mice were followed-up for 30 weeks. The retinal morphology and function was examined in vivo using fundus imaging and electroretinography at 15- and 30-weeks follow-up. At the end of the study, at 36 weeks of age, eye tissues were collected and retinal sections were examined using light microscopy and transmission electron microscopy.
RESULTS: Fundus images of the HFD-fed mice showed the presence of discrete, multiple white spots, which was significantly reduced by approximately 73% in the simvastatin-treated animals. In the HFD-fed mice, there was an increase in the empty cytoplasmic vacuoles of the RPE, presence of lipid droplets in the BM, thickening and fragmentation of the elastic lamina of the BM, and a reduction in retinal function; these ultrastructural and functional changes were significantly improved in the simvastatin-treated group.
CONCLUSIONS: Chronic administration of simvastatin significantly improves the ultrastructure and function of the RPE, BM, and photoreceptor in a high-fat atherogenic mouse model of thickened BM.

Entities:  

Keywords:  Bruch's membrane; electroretinography; high-fat atherogenic mouse model; retina; simvastatin

Mesh:

Substances:

Year:  2014        PMID: 24398101     DOI: 10.1167/iovs.13-11636

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  12 in total

1.  The ocular toxicity and pharmacokinetics of simvastatin following intravitreal injection in mice.

Authors:  Dennis Y Tse; Seong Jae Kim; Inyoung Chung; Feng He; Theodore G Wensel; Samuel M Wu
Journal:  Int J Ophthalmol       Date:  2017-09-18       Impact factor: 1.779

2.  Cholesterol in mouse retina originates primarily from in situ de novo biosynthesis.

Authors:  Joseph B Lin; Natalia Mast; Ilya R Bederman; Yong Li; Henri Brunengraber; Ingemar Björkhem; Irina A Pikuleva
Journal:  J Lipid Res       Date:  2015-12-02       Impact factor: 5.922

Review 3.  Cholesterol in the retina: the best is yet to come.

Authors:  Irina A Pikuleva; Christine A Curcio
Journal:  Prog Retin Eye Res       Date:  2014-04-04       Impact factor: 21.198

4.  Pathways of cholesterol homeostasis in mouse retina responsive to dietary and pharmacologic treatments.

Authors:  Wenchao Zheng; Natalia Mast; Aicha Saadane; Irina A Pikuleva
Journal:  J Lipid Res       Date:  2014-10-07       Impact factor: 5.922

Review 5.  Impacts of high fat diet on ocular outcomes in rodent models of visual disease.

Authors:  Danielle A Clarkson-Townsend; Amber J Douglass; Anayesha Singh; Rachael S Allen; Ivie N Uwaifo; Machelle T Pardue
Journal:  Exp Eye Res       Date:  2021-01-11       Impact factor: 3.467

6.  A High Fat "Western-style" Diet Induces AMD-Like Features in Wildtype Mice.

Authors:  Eloise Keeling; Savannah A Lynn; Yen Min Koh; Jenny A Scott; Aaron Kendall; Maureen Gatherer; Anton Page; Felino R Cagampang; Andrew J Lotery; J Arjuna Ratnayaka
Journal:  Mol Nutr Food Res       Date:  2022-04-28       Impact factor: 6.575

7.  Atorvastatin Promotes Phagocytosis and Attenuates Pro-Inflammatory Response in Human Retinal Pigment Epithelial Cells.

Authors:  Bo Tian; Ahmad Al-Moujahed; Peggy Bouzika; Yijun Hu; Shoji Notomi; Pavlina Tsoka; Joan W Miller; Haijiang Lin; Demetrios G Vavvas
Journal:  Sci Rep       Date:  2017-05-24       Impact factor: 4.379

Review 8.  The Question of a Role for Statins in Age-Related Macular Degeneration.

Authors:  Marina Roizenblatt; Nara Naranjit; Mauricio Maia; Peter L Gehlbach
Journal:  Int J Mol Sci       Date:  2018-11-21       Impact factor: 5.923

9.  Alterations of retinal thickness measured by optical coherence tomography correlate with neurophysiological measures in diabetic polyneuropathy.

Authors:  Yuichiro Yamada; Tatsuhito Himeno; Kotaro Tsuboi; Yuka Shibata; Miyuka Kawai; Yuriko Asada-Yamada; Yusuke Hayashi; Emi Asano-Hayami; Tomohide Hayami; Yuichiro Ishida; Yohei Ejima; Mikio Motegi; Saeko Asano; Makoto Kato; Eriko Nagao; Hiromi Nakai-Shimoda; Takahiro Ishikawa; Yoshiaki Morishita; Masaki Kondo; Shin Tsunekawa; Yoshiro Kato; Takayuki Nakayama; Motohiro Kamei; Jiro Nakamura; Hideki Kamiya
Journal:  J Diabetes Investig       Date:  2020-12-30       Impact factor: 4.232

10.  Regression of Some High-risk Features of Age-related Macular Degeneration (AMD) in Patients Receiving Intensive Statin Treatment.

Authors:  Demetrios G Vavvas; Anthony B Daniels; Zoi G Kapsala; Jeremy W Goldfarb; Emmanuel Ganotakis; John I Loewenstein; Lucy H Young; Evangelos S Gragoudas; Dean Eliott; Ivana K Kim; Miltiadis K Tsilimbaris; Joan W Miller
Journal:  EBioMedicine       Date:  2016-02-04       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.